Neuregulin-1/ErbB network: An emerging modulator of nervous system injury and repair
- PMID: 31229498
- DOI: 10.1016/j.pneurobio.2019.101643
Neuregulin-1/ErbB network: An emerging modulator of nervous system injury and repair
Abstract
Neuregulin-1 (Nrg-1) is a member of the Neuregulin family of growth factors with essential roles in the developing and adult nervous system. Six different types of Nrg-1 (Nrg-1 type I-VI) and over 30 isoforms have been discovered; however, their specific roles are not fully determined. Nrg-1 signals through a complex network of protein-tyrosine kinase receptors, ErbB2, ErbB3, ErbB4 and multiple intracellular pathways. Genetic and pharmacological studies of Nrg-1 and ErbB receptors have identified a critical role for Nrg-1/ErbB network in neurodevelopment including neuronal migration, neural differentiation, myelination as well as formation of synapses and neuromuscular junctions. Nrg-1 signaling is best known for its characterized role in development and repair of the peripheral nervous system (PNS) due to its essential role in Schwann cell development, survival and myelination. However, our knowledge of the impact of Nrg-1/ErbB on the central nervous system (CNS) has emerged in recent years. Ongoing efforts have uncovered a multi-faceted role for Nrg-1 in regulating CNS injury and repair processes. In this review, we provide a timely overview of the most recent updates on Nrg-1 signaling and its role in nervous system injury and diseases. We will specifically highlight the emerging role of Nrg-1 in modulating the glial and immune responses and its capacity to foster neuroprotection and remyelination in CNS injury. Nrg-1/ErbB network is a key regulatory pathway in the developing nervous system; therefore, unraveling its role in neuropathology and repair can aid in development of new therapeutic approaches for nervous system injuries and associated disorders.
Keywords: CNS injury and repair; ErbB signaling; Myelination and myelin repair; Neuregulin-1; Neuroinflammation; PNS injury.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish.Curr Biol. 2005 Mar 29;15(6):513-24. doi: 10.1016/j.cub.2005.02.030. Curr Biol. 2005. PMID: 15797019
-
Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system.Neuron. 2008 Aug 28;59(4):581-95. doi: 10.1016/j.neuron.2008.06.028. Neuron. 2008. PMID: 18760695 Free PMC article.
-
Localization of neuregulin isoforms and erbB receptors in myelinating glial cells.Glia. 2004 Jan 15;45(2):197-207. doi: 10.1002/glia.10311. Glia. 2004. PMID: 14730713
-
The neuregulin-I/ErbB signaling system in development and disease.Adv Anat Embryol Cell Biol. 2007;190:1-65. Adv Anat Embryol Cell Biol. 2007. PMID: 17432114 Review.
-
New insights into signaling during myelination in zebrafish.Curr Top Dev Biol. 2011;97:1-19. doi: 10.1016/B978-0-12-385975-4.00007-3. Curr Top Dev Biol. 2011. PMID: 22074600 Free PMC article. Review.
Cited by
-
Functional EGF domain of the human neuregulin 1α produced in Escherichia coli with accurate disulfide bonds.Mol Biol Rep. 2022 Dec;49(12):11715-11727. doi: 10.1007/s11033-022-07956-3. Epub 2022 Oct 5. Mol Biol Rep. 2022. PMID: 36198848
-
Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms.BMC Psychiatry. 2022 Mar 25;22(1):217. doi: 10.1186/s12888-022-03856-9. BMC Psychiatry. 2022. PMID: 35337293 Free PMC article.
-
Validated determination of NRG1 Ig-like domain structure by mass spectrometry coupled with computational modeling.Commun Biol. 2022 May 12;5(1):452. doi: 10.1038/s42003-022-03411-y. Commun Biol. 2022. PMID: 35551273 Free PMC article.
-
Genetic variants for head size share genes and pathways with cancer.Cell Rep Med. 2024 May 21;5(5):101529. doi: 10.1016/j.xcrm.2024.101529. Epub 2024 May 3. Cell Rep Med. 2024. PMID: 38703765 Free PMC article.
-
Systemic HER3 ligand-mimicking nanobioparticles enter the brain and reduce intracranial tumour growth.Nat Nanotechnol. 2025 May;20(5):683-696. doi: 10.1038/s41565-025-01867-7. Epub 2025 Feb 21. Nat Nanotechnol. 2025. PMID: 39984637 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous